HOME >> MEDICINE >> NEWS
Exposed: Tobacco companies efforts to influence industry privatisation

A paper in this week's issue of THE LANCET highlights how two tobacco companies attempted to influence plans to privatise the state-owned tobacco industry in Moldova.

Moldova, a small, agriculturally dependent state of 4.3 million people is Europe's poorest country. In October 2000, after pressure from the International Monetary Fund the Moldovan government approved a bill to privatise its tobacco industry.

Anna Gilmore (London School of Hygiene and Tropical Medicine, UK) and colleagues analysed internal tobacco industry documents on Moldova made public through litigation. The documents suggest that although a competitive tender for the state owned monopoly was later announced, British American Tobacco (BAT) and the German manufacturer Reemtsma each initially sought to secure a closed deal. BAT sought to acquire a monopoly position, bolstered by excise rules developed by the company that would uniquely favour its products. Documents suggest that BAT attempted to gain favour in various ways including donating funds in aid of flood relief and providing Moldova with agricultural machinery. Despite hoping to establish a monopoly, BAT planned intensive marketing, as if in a competitive market, aiming to target young people in cities. In doing so it predicted that smoking uptake would increase, especially among women, belying the tobacco industry claim that advertising only encourages brand switching. The documents also suggest that BAT planned to cull the cigarette-processing workforce in Moldova but present 'sanitised' information on future employment levels to the Moldovans.

Dr Gilmore comments: "It is evident from the tactics revealed here that countries undertaking tobacco industry privatisation and the organisations advising them need to ensure a transparent process and a truly competitive tender in order to maximise potential revenue gains. To prevent the predicted increase in consumption likely to arise through the growth of advertising a
'"/>

Contact: Udani Samarasekera
pressoffice@lancet.com
44-207-424-4949
Lancet
7-Apr-2005


Page: 1 2

Related medicine news :

1. Tobacco and alcohol use independently increase risk of head and neck cancer
2. Tobacco companies obstructed science, history professor says
3. Tobacco companies admit their products cause cancer, but not in those who sue them
4. On World NO Tobacco Day the ESC urges governments to spread smoking bans & tax tobacco
5. Tobacco smoke linked to allergic rhinitis in infants
6. Tobacco industry developed product strategy to conceal toxicity of cigarettes
7. Tobacco industry promoted ineffective ventilation systems
8. Mayo Clinic Tobacco Quitline to provide Minnesota QUITPLAN Helpline service
9. Tobacco linked to 63 percent of cancer death burden among African-American men
10. Tobacco companies designed cigarettes to addict women, according to new study
11. Tobacco use persists after liver transplant for alcoholic liver disease

Post Your Comments:
(Date:5/21/2013)... (PRWEB) May 21, 2013 DISCcert has ... showing how to use 17 DISC applications at the ... a natural progression. , The July 25 & 26th ... top 17 ways of applying DISC. The time-tested, proven ... graduates. The user-friendly DISC training materials ; ...
(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... dedicated to protecting the rights of victims injured by ... the Journal of Bone & Joint Surgery on May ... (MRI) can be used to identify complications that occur ... have any symptoms of failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) ...
(Date:5/21/2013)... stent, which is a novel stent platform eluting ... the Xience Prime everolimus-eluting stent for the primary ... nine months in the results of an imaging ... BIOFLOW-II substudy used intravascular ultrasound (IVUS) and optical ... and stent apposition at nine months after treating ...
(Date:5/21/2013)... 21, 2013 Phoseon Technology will present ... the 20th Annual IMI European Ink Jet Conference ... leader, Phoseon continues to invest in product development to ... of UV LED curing in printing applications. Phoseon ... the market offering both air cooled and water cooled ...
(Date:5/21/2013)... AURORA, Colo. (May 21, 2013) A paper recently ... and co-written by physicians and scientists at the ... important genetic risk factor for pulmonary fibrosis can be ... lung disease. , Researchers looked at a fairly common ... is a component of the mucous produced by the ...
Breaking Medicine News(10 mins):Health News:DISCcert Offers 17 Applications in Coming DISC Certification 2Health News:DISCcert Offers 17 Applications in Coming DISC Certification 3Health News:DISCcert Offers 17 Applications in Coming DISC Certification 4Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2
(Date:5/21/2013)... 2013  Lehigh Valley Health Network has announced the ... adding to its existing arsenal of five 5-foot-5 germ-killing ... within the network, LVHN is now deploying the largest ... superbugs and provide the best possible patient care available. ... TRU-D – the signature product of Memphis ...
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May 21, ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... online the positive Phase 2a study results of dupilumab ... an investigational monoclonal antibody targeting the alpha subunit of ... of both IL-4 and IL-13, drivers of Th2 (Type ...
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2
Cached News: